In its latest report on Acute Myeloid Leukemia Testing Market provides a concise analysis of the recent market trends. The report further includes statistics, market forecasts and revenue estimations, which in addition highlights its status in the competitive domain as well as expansion trends adopted by major industry players.
Acute Myeloid Leukemia Testing Market Size 2020
Global Acute Myeloid Leukemia Testing Market is expected to grow with the CAGR of 5.8% over the forecast period.
Get Sample Copy of This Premium Report @ https://brandessenceresearch.com/requestSample/PostId/1369
Scope of Acute Myeloid Leukemia Testing Market
Acute Myeloid Leukemia is a type of cancer in which the bone marrow makes and spread to other organs, a wide range of symptoms can develop due to the blast cells enter the central nervous system. Acute myeloid leukemia involves the body producing too many nonfunctioning, immature white blood cells. Acute leukemia develops suddenly, while chronic leukemia lasts for a long time and progresses gradually. The general symptoms of acute myeloid leukemia can be similar to those of the flu such as fatigue, breathlessness, sweating more than usual, pallor, skin that bruises easily, a fever and other. Blood tests are generally the first tests done to look for leukemia. Blood is taken from a vein in the arm. Leukemia starts in the bone marrow, so checking the bone marrow for leukemia cells is a key part of testing for it.
Global Acute Myeloid Leukemia Testing Market report is segmented on the basis of biomarker type, end-user and region & country level. Based upon biomarker type, the acute myeloid leukemia testing market is segmented into genetic acute myeloid leukemia (AML) biomarker, epigenetic acute myeloid leukemia (AML) biomarker and proteomic acute myeloid leukemia (AML) biomarker. Based upon end-user, market is divided hospitals, cancer diagnostic centers, research institutes and others.
The regions covered in this acute myeloid leukemia testing market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of acute myeloid leukemia testing sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Acute Myeloid Leukemia Testing Companies 2020
Global Acute myeloid leukemia testing report covers prominent player’s
- NeoGenomics Laboratories, Inc.
- QIAGEN
- Invivoscribe, Inc.
- Illumina, Inc.
- ArcherDx, Inc.
- ARUP Laboratories
- ASURAGEN, INC.
- Mayo Foundation for Medical Education and Research
- Laboratory Corporation of America Holdings
- Dr Lal PathLab
- Hoffmann-La Roche Ltd
- Abbott Laboratories
- Thermo Fisher Scientific Inc.
- Cancer Genetics Inc.
- SkylineDx B.V.
Request for Methodology @ https://brandessenceresearch.com/requestMethodology/PostId/1369
Acute Myeloid Leukemia Testing News
Precipio Launched its Proprietary HemeScreen AML (Acute Myeloid Leukemia) Molecular Panel
September 22nd, 2020; Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), launched its HemeScreen AML (Acute Myeloid Leukemia) panel both clinically in its CLIA laboratory, and as part of its HemeScreen product offering. This new panel expands the HemeScreen offering for reference laboratories and physician office laboratories, enabling them to provide improved patient care through faster turnaround time.
Advancement in Pharmacology and Molecular Biology to Promote Drug Development is one of the Major Factors Driving the Global Acute Myeloid Leukemia Testing Market.
Rapidly increasing incidences and prevalence of acute myeloid leukemia is of the major factors driving the growth of global acute myeloid leukemia testing market. According to American Cancer Society; it is estimated that for leukemia in the United States for 2020 are about 60,530 new cases of leukemia (all kinds) and 23,100 deaths from leukemia. Increasing need of advanced therapeutics is also a high-impact rendering driver of this market. In addition, increasing geriatric population base and growing unmet healthcare needs are also expected to boost the market growth further. However, stringent regulations on drugs and complications related to chemotherapy may hamper the market growth within the forecast period. In spite of that, increasing investment in research and development and technological advancement may create the number of opportunities for the further growth of the market.
North America is expected to Dominate the Global Acute Myeloid Leukemia Testing Market.
North America is expected to dominate the global acute myeloid leukemia testing market. Advanced healthcare infrastructure, rising need of targeted therapies, huge investment in the development of drugs are some of the major factors responsible for market growth in this region within the forecast period. In addition, increasing technological advancement in healthcare sector and increased awareness about genetic testing are also fostering the market growth in this region. According to American Cancer Society’s estimates for leukemia in the United States for 2020 are around 19,940 new cases of acute myeloid leukemia. Asia pacific is becoming an emerging market for myeloid leukemia testing due to the increasing awareness about acute myeloid leukemia testing in this region. Increasing inclination towards therapies such as targeted therapies resulting in low collateral damage and stronger efficacy is also supplementing the market growth in this region. For example, according to MBCV In 2017, there were 11,923 combined new cases of leukemia, lymphoma and myeloma in Australia.
Complete Report Details @ https://brandessenceresearch.com/healthcare/acute-myeloid-leukemia-testing-market-industry
Key Benefits for Global Acute Myeloid Leukemia Testing Market Report-
- Global acute myeloid leukemia testing market report covers in depth historical and forecast analysis.
- Global acute myeloid leukemia testing market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
- Global acute myeloid leukemia testing market report helps to identify opportunities in market place.
- Global acute myeloid leukemia testing market report covers extensive analysis of emerging trends and competitive landscape.
Global Acute Myeloid Leukemia Testing Market Segmentation:
By Biomarker Type:
- Genetic Acute Myeloid Leukemia (AML) Biomarker
- Epigenetic Acute Myeloid Leukemia (AML) Biomarker
- Proteomic Acute Myeloid Leukemia (AML) Biomarker
By End-User:
- Hospitals
- Cancer diagnostic Centers
- Research Institutes
- Others
Regional & Country Analysis
North America, U.S., Mexico, Canada , Europe, UK, France, Germany, Italy , Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa
Table of Content
1. Chapter – Report Methodology
1.1. Research Process
1.2. Primary Research
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model
1.7. USP’s of Report
1.8. Report Description
2. Chapter – Global Acute Myeloid Leukemia Testing Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary
2.3. Global Acute Myeloid Leukemia Testing Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Acute Myeloid Leukemia Testing Market: Trends
2.8. Porter’s Five Forces Analysis
2.9. Market Attractiveness Analysis
3. Chapter – Global Acute Myeloid Leukemia Testing Market Overview: Quantitative Analysis
4. Chapter – Global Acute Myeloid Leukemia Testing Market Analysis: Segmentation By Type
5. Chapter – Global Acute Myeloid Leukemia Testing Market Analysis: Segmentation By Application
Continued…
About Us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at sales@brandessenceresearch.com
Website: https://brandessenceresearch.com/
Article: https://businessstatsnews.com
Blog: https://marketsize.biz
